1.
Benjamin Victor Ineichen. We need less animal research, better animal research, and animal research done for the right reasons. Journal of Translational Medicine. 2026. doi:10.1186/s12967-026-08259-y
Ethics, policy, and legislation
1.
Kristof Dhont, Gordon Hodson. Speciesism and the psychology of animal exploitation. Nature Reviews Psychology. 2026:1-15. doi:10.1038/s44159-026-00585-8
1.
Matthias Eggel, Samuel Camenzind, Paulin Jirkof. Reasons to Reduce Surplus Animals in Research (in Switzerland) – Or Why the Killing and Death of Animals and Potentially Standard Husbandry Conditions Should be Classified as Harms. LEOH - Journal of Animal Law, Ethics and One Health. 2026:1-15. doi:10.58590/leoh.2026.001
1.
M. V. Olson. Institutional Biobanking as shared public health infrastructure: a financially sustainable service center model. Frontiers in Health Services. 2026;6. doi:10.3389/frhs.2026.1778446
1.
Ashley L. Eadie, Holly Fernandez Lynch, Naomi Scheinerman, Ravi B. Parikh. Advancing FDA New Approach Methodologies from animal models through digital twins. npj Digital Medicine. 2026. doi:10.1038/s41746-026-02476-x
1.
Emmanuel Enoch Dzakah, Chao Ni, Xiaomin Feng, et al. Modernizing drug development and ensuring global equity in the organoid revolution. Communications Biology. 2026;9(1):540. doi:10.1038/s42003-026-10076-4
1.
Julia Matyjasiak, Alexandra-Costina Avîrvarei, Marie Corradi, et al. Mapping 3Rs and NAM research and innovation projects funded through European framework programmes since 2007. Archives of Toxicology. 2026. doi:10.1007/s00204-026-04383-2
1.
Matthias Eggel, Samuel Camenzind, Paulin Jirkof. Reasons to Reduce Surplus Animals in Research (in Switzerland) – Or Why the Killing and Death of Animals and Potentially Standard Husbandry Conditions Should be Classified as Harms. LEOH - Journal of Animal Law, Ethics and One Health. 2026:1-15. doi:10.58590/leoh.2026.001
1.
Federico Germani, Julian W. März, Alessandro Luciani, Olivier Devuyst, Nikola Biller-Andorno. Ethical and legal considerations of digital animal models: pioneering reduction and replacement. Trends in Biotechnology. 2026;44(3):593-595. doi:10.1016/j.tibtech.2025.08.011
1.
Michael J. Fossler, C. Edwin Garner. The FDA Roadmap to Reducing Animal Testing in Preclinical Safety Studies: Where Will It Lead Us? Clinical Pharmacology in Drug Development. 2026;15(3):e70046. doi:10.1002/cpdd.70046